NTR-1011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NTR-1011, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA [Phase 1]